Showing results (111-120 of 262) with videos related to
Sort By:
Pageof 27
The Journal of Trauma|July 1, 1996
Fluconazole increases bactericidal activity of neutrophilsE E Zervos, S S Bass, M C Robson, et al.Lasers in Surgery and Medicine|January 1, 1991
Alternative lasers for endoscopic surgery: comparison of pulsed thulium-holmium-chromium:YAG with continuous-wave neodymium:YAG laser for ablation of colonic mucosaL S Bass, M C Oz, S L Trokel, et al.Anesthesia and Analgesia|February 23, 2008
An efficient screening tool for preoperative depression: the Geriatric Depression Scale-Short FormDiana S Bass, Deborah K Attix, Barbara Phillips-Bute, et al.Surgical Endoscopy|January 1, 1990
Anastomosis of biliary tissue with high-frequency electrical diathermyL S Bass, H W Popp, M C Oz, et al.British Journal of Pharmacology|June 25, 2008
Moving towards better predictors of drug-induced torsades de pointesA S Bass, B Darpo, J-P Valentin, et al.Journal of Molecular Biology|October 5, 1985
Specificity of insertion of IS1D Zerbib, P Gamas, M Chandler, et al.Genes & Development|August 1, 1987
DNA specificity determinants of Escherichia coli tryptophan repressor bindingS Bass, P Sugiono, D N Arvidson, et al.Journal of Cardiovascular Pharmacology|April 1, 1989
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drugA S Bass, M B Murphy, J D Kohli, et al.Immunotherapy|November 8, 2011
Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumorsMelissa G Lechner, Sarah M Russell, Rikki S Bass, et al.Cancer Biology & Therapy|November 15, 2006
Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signalingAdda Grimberg, Carrie M Coleman, Zonggao Shi, et al.Pageof 27